• Profile
Close

Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: A phase 2 and 3 multicenter, double-blind, randomized, placebo-controlled trial

The Lancet Feb 01, 2022

The safety and efficacy profile of the COVID-19 vaccine SCB-2019 has been reported in this study.

  • In this ongoing phase 2 and 3 double-blind, placebo-controlled trial, adults aged 18 years and older who were in good health or with a stable chronic health condition were included and randomly assigned 1:1 to receive two 0·5 mL intramuscular doses of SCB-2019 (30 μg, adjuvanted with 1·50 mg CpG-1018 and 0·75 mg alum) or placebo (0·9% sodium chloride for injection supplied in 10 mL ampoules) 21 days apart.

  • From March 24, 2021, until the cutoff date of Aug 10, 2021, enrollment of 30,174 participants was done; 30,128 of these received their first assigned vaccine (n = 15,064) or a placebo injection (n = 15,064).

  • A total of 12,355 baseline SARS-CoV-2-naive participants (6251 vaccines and 6104 placebo recipients) comprised the per-protocol population.

  • COVID-19 was diagnosed in 207 after the second dose at 14 days, 52 vaccines vs 155 placebo recipients.

  • The overall vaccine efficacy was 67·2% against any COVID-19 severity, 83·7% against moderate-to-severe COVID-19, and 100% against severe COVID-19.

  • Overall, participants receiving two doses of SCB-2019 vaccine plus CpG and alum showed development of notable protection against the entire severity spectrum of COVID-19 caused by circulating SAR-CoV-2 viruses, including the predominating delta variant.

  • There emerged no safety issues in the follow-up period for the efficacy analysis (median of 82 days).

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay